Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, ...

GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for ...

High-sensitivity C-reactive protein (CRP) decreased significantly in the semaglutide group, with estimated treatment ratios ...

Researchers found long-term treatment could delay progression from mild cognitive impairment to moderate Alzheimer’s disease ...

An Alzheimer’s drug which has been rejected for NHS use can slow disease progression by eight years, researchers have claimed ...

"Spinogenix’s Alzheimer’s drug touts disease-modifying potential in Phase IIa study" was originally created and published by ...

Explore how smart pillboxes and dispensers help people with early-stage Alzheimer's manage medications effectively, ensuring ...

The experimental drug neflamapimod reduced a key biomarker of neurodegeneration, which correlated with a slowing of cognitive ...

We knew that GLP-1 drugs like Ozempic and Wegovy did more than just help control type 2 diabetes and aid weight loss, but the ...

It is widely known that Alzheimer's disease is mainly associated with the overproduction of β-amyloid peptides and damage ...

Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term ...

The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...